logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Q

Qingqing Cai

Sun Yat-sen University Cancer Center
H指数:35
被引数:4,924

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial

脂质体米托蒽醌联合替雷利珠单抗在复发或难治性结外自然杀伤/T细胞淋巴瘤患者中的治疗：一项1b/2期临床试验

Nature Communications
IF15.7
2026-06-150
OAAI
Qihua Zou; Shenrui Bai; Liang Wang; Hongyan Tong; Dongfeng Zeng; Ying Zhao; Yuerong Shuang; Xiaobo Wang; Xiuhua Sun; Zhenya Hong; Zhigang Peng; Yu Yang; Runhui Zheng; Huiqiang Huang; Jianbo Liu; Chunmei Yang; Xi Li; Xin Gao; Hao Xu; Daoguang Chen; Xiaojie Fang; Man Nie; Jinni Wang; Xinna Gao; Jingjing Ye; Wei Zhang; Jianzhen Shen; Rong Tao; Hong Cen; Yuchen Zhang; Jun Cai; Yi Xia; Qingqing Cai
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

套细胞淋巴瘤巩固治疗的治疗演变及对生存的影响：来自亚太地区真实世界登记研究的见解

Blood Cancer Journal
IF11.6
2026-05-290
OAAI
Hyungwoo Cho; Koji Kato; Jason Yongsheng Chan; Kim Dajung; Haiwen Huang; Qingqing Cai; Tongyu Lin; Udomsak Bunworasate; Sen-Mui Tan; Ka-Won Kang; Jae-Yong Kwak; Tsai-Yun Chen; Jeong-Ok Lee; Seong Hyun Jeong; Young Rok Do; Esther Chan; Hye Jin Kang; Hyeon-Seok Eom; Sung Yong Oh; Youngil Koh; Hyo Jung Kim; Se-Hyung Kim; Jong Ho Won; Young Hoon Park; Deok Hwan Yang; Soo Chin Ng; Jae-Cheol Jo; Hilman Tadjoedin; Anna Mira Lubis; Noorwati Sutandyo; Tsuyoshi Muta; Ken Takase; Dok Hyun Yoon; Won Seog Kim
Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial

泽鲁布替尼联合利妥昔单抗，随后进行缩短的化疗免疫疗法作为套细胞淋巴瘤的一线治疗方案（CHESS）：一项II期试验

Nature Communications
IF15.7
2026-03-280
OAAI
Yuchen Zhang; Man Nie; Yi Cao; Zhiming Li; He Huang; Guowei Li; Xiuhua Sun; Panpan Liu; Yan Gao; Xiaojie Fang; Bing Bai; Jun Cai; Lirong Li; Yingxian Liu; Sihua Peng; Huiqiang Huang; Yi Xia; Qingqing Cai
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)

二线系统性治疗后外周T细胞淋巴瘤患者中，选择性JAK1抑制剂golidocitinib的多中心维持治疗研究（JACKPOT26）

Blood Cancer Journal
IF11.6
2026-03-170
OAAI
Juying Wei; Qingqing Cai; Liling Zhang; Liqun Zou; Zengjun Li; Keshu Zhou; Huijing Wu; Lihua Qiu; Liping Su; Kaiyang Ding; Hui Zhou; Li Yu; Fei Li; Wenyu Li; Li’e Lin; Qing Xiao; Erhua Wang; Hongmei Jing; Meifang Zheng; Hongyu Zhang; Yuhuan Gao; Da Gao; Lijia Chen; Jie Jin
TQB3617, a bromodomain and extra-terminal inhibitor, in patients with relapsed or refractory lymphoma: A multicenter, phase 1 trial

TQB3617，一种溴域和末端外抑制剂，在复发或难治性淋巴瘤患者中的研究：一项多中心、I期临床试验

Med
IF11.8
2025-10-270
PRE
Yuchen Zhang; Qingsong Yin; Baitian Zhao; Fang Liu; Su Li; Jun Cai; Xiaojie Fang; Bing Bai; Man Nie; Qihua Zou; Dawei Ding; Xin Wang; Jiajia Zhu; Ding Yu; Xunqiang Wang; Xiquan Zhang; Liang Wang; Yi Xia; Qingqing Cai

研究方向

暂未获取到该数据
Y
Yuchen Zhang
H 指数:16论文数:83被引数:1,018
蔡
蔡俊
H 指数:33论文数:221被引数:2,799
刘
刘盼盼
H 指数:35论文数:194被引数:3,913
W
Wenming Wei
H 指数:8论文数:45被引数:209
X
Xiaoge Chu
H 指数:8论文数:31被引数:171
Y
Yijing Zhao
H 指数:18论文数:116被引数:1,840
和丹 封面图
和丹
H 指数:15论文数:70被引数:895
贾
贾雨萌
H 指数:18论文数:193被引数:1,426
X
Xiaoyue Qin
H 指数:8论文数:35被引数:259
S
Sirong Shi
H 指数:7论文数:28被引数:126